Enzyme-linked immunosorbent assay (ELISA) confirmed that the expression level of IL-8 was increased in GFP-CPAP/Hep3B cells upon IL-6 treatment (Fig. 4c), and the serum expression level of IL-8 was positively correlated with CPAP overexpression in HCC patients (Fig. 4d). The gene discussed is IL6; the disease is hepatocellular carcinoma.